Evidence map›Paper›PMID 24927585›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Probing the paramyxovirus fusion (F) protein-refolding event from pre- to postfusion by oxidative footprinting.

Taylor A Poor, Lisa M Jones, Amika Sood, George P Leser, Manolo D Plasencia, Don L Rempel, Theodore S Jardetzky, Robert J Woods, Michael L Gross, Robert A Lamb

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Taylor A PoorDepartment of Molecular Biosciences and.
Lisa M JonesDepartment of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202;
Amika SoodComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602;
George P LeserDepartment of Molecular Biosciences andHoward Hughes Medical Institute, Northwestern University, Evanston, IL 60208;
Manolo D PlasenciaDepartment of Chemistry, Washington University in St. Louis, St. Louis, MO 63130;
Don L RempelDepartment of Chemistry, Washington University in St. Louis, St. Louis, MO 63130;
Theodore S JardetzkyDepartment of Structural Biology, Stanford University, Stanford, CA 94305; and.
Robert J WoodsComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602;School of Chemistry, National University of Ireland, Galway, Ireland.
Michael L GrossDepartment of Chemistry, Washington University in St. Louis, St. Louis, MO 63130;
Robert A LambDepartment of Molecular Biosciences andHoward Hughes Medical Institute, Northwestern University, Evanston, IL 60208; ralamb@northwestern.edu.

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
CELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1M
TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
STRUCTURAL STUDIES OF PARAMYXOVIRUS FUSION PROTEINSR01GM061050 · NIGMS · STANFORD UNIVERSITY · PI JARDETZKY, THEODORE S · 2000 to 2015
$3.1M
STRUCTURE &EXPRESSION OF THE PARAMYXOVIRUS SV5 GENOMER01AI023173 · NIAID · NORTHWESTERN UNIVERSITY · PI LAMB, ROBERT A · 1986 to 2010
$3.1M
Integrating Experiment and Theory to Characterize Diagnostic Antibody SpecificityR01GM094919 · NIGMS · UNIVERSITY OF GEORGIA · PI WOODS, ROBERT J · 2010 to 2013
$1.7M
Training Program in Viral ReplicationT32AI060523 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LAIMINS, LAIMONIS A. · 2004 to 2013
$1.4M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA060553NIAID NIH HHS R01 AI023173NIAID NIH HHS R01-AI-23173NIAID NIH HHS T32 AI060523NIAID NIH HHS T32-AI-060523NIGMS NIH HHS P41 GM103390NIGMS NIH HHS P41-GM-103390NIGMS NIH HHS P41 GM103422NIGMS NIH HHS R01 GM061050NIGMS NIH HHS R01 GM094919NIGMS NIH HHS R01-GM-094919NIGMS NIH HHS R01-GM-61050NIGMS NIH HHS T32 GM008061NIGMS NIH HHS T32-GM008061
6 · The paper itself

Abstract

To infect a cell, the Paramyxoviridae family of enveloped viruses relies on the coordinated action of a receptor-binding protein (variably HN, H, or G) and a more conserved metastable fusion protein (F) to effect membrane fusion and allow genomic transfer. Upon receptor binding, HN (H or G) triggers F to undergo an extensive refolding event to form a stable postfusion state. Little is known about the intermediate states of the F refolding process. Here, a soluble form of parainfluenza virus 5 F was triggered to refold using temperature and was footprinted along the refolding pathway using fast photochemical oxidation of proteins (FPOP). Localization of the oxidative label to solvent-exposed side chains was determined by high-resolution MS/MS. Globally, metastable prefusion F is oxidized more extensively than postfusion F, indicating that the prefusion state is more exposed to solvent and is more flexible. Among the first peptides to be oxidatively labeled after temperature-induced triggering is the hydrophobic fusion peptide. A comparison of peptide oxidation levels with the values of solvent-accessible surface area calculated from molecular dynamics simulations of available structural data reveals regions of the F protein that lie at the heart of its prefusion metastability. The strong correlation between the regions of F that experience greater-than-expected oxidative labeling and epitopes for neutralizing antibodies suggests that FPOP has a role in guiding the development of targeted therapeutics. Analysis of the residue levels of labeled F intermediates provides detailed insights into the mechanics of this critical refolding event.

Indexed as

Protein RefoldingOxidation-ReductionParainfluenza Virus 5PeptidesViral Fusion ProteinsPeptidesViral Fusion Proteinsmass spectroscopyprotein refoldingviral fusion protein

Identifiers

PMID24927585
PMCPMC4078851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.